Coumarin and Chromen-4-one Analogues as Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor: Discovery and X-ray Crystallography
- 30 December 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (4) , 540-547
- https://doi.org/10.1021/jm000386o
Abstract
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine released from T-cells and macrophages. Although a detailed understanding of the biological functions of MIF has not yet been clarified, it is known that MIF catalyzes the tautomerization of a nonphysiological molecule, d-dopachrome. Using a structure-based computer-assisted search of two databases of commercially available compounds, we have found 14 novel tautomerase inhibitors of MIF whose Ki values are in the range of 0.038−7.4 μM. We also have determined the crystal structure of MIF complexed with the hit compound 1. It showed that the hit compound is located in the active site of MIF containing the N-terminal proline which plays an important role in the tautomerase reaction and forms several hydrogen bonds and undergoes hydrophobic interactions. A crystallographic study also revealed that there is a hydrophobic surface which consists of Pro-33, Tyr-36, Trp-108, and Phe-113 at the rim of the active site of MIF, and molecular modeling studies indicated that several more potent hit compounds have the aromatic rings which can interact with this hydrophobic surface. To our knowledge, our compounds are the most potent tautomerase inhibitors of MIF. One of these small, drug-like molecules has been cocrystallized with MIF and binds to the active site for tautomerase activity. Molecular modeling also suggests that the other hit compounds can bind in a similar fashion.Keywords
This publication has 23 references indexed in Scilit:
- Crystal Structure of 4-Oxalocrotonate Tautomerase Inactivated by 2-Oxo-3-pentynoate at 2.4 Å Resolution: Analysis and Implications for the Mechanism of Inactivation and Catalysis,Biochemistry, 1998
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- Crystal structure of macrophage migration inhibitory factor from human Å lymphocyte at 2.1 Å resolutionFEBS Letters, 1996
- Structural classification of proteins: new superfamiliesCurrent Opinion in Structural Biology, 1996
- Enzymatic Ketonization of 2-Hydroxymuconate: Specificity and Mechanism Investigated by the Crystal Structures of Two IsomerasesBiochemistry, 1996
- MIF as a glucocorticoid-induced modulator of cytokine productionNature, 1995
- MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemiaNature, 1993
- Structure-Based Discovery of Inhibitors of Thymidylate SynthaseScience, 1993
- Structure-Based Strategies for Drug Design and DiscoveryScience, 1992
- Near-coincidence orientations in hexagonal materials: from a unified twin approach to a quasiperiodic descriptionActa Crystallographica Section A Foundations of Crystallography, 1991